Aug 15, 2017 12:30 pm UTC| Business
The Company has Generated Revenues and Advanced in RD for Intranasal Ampligen and in Immuno-Oncology Conference Call Scheduled for Tuesday, August 15th at 1:00 PM EDT PHILADELPHIA, Aug. 15, 2017 -- Hemispherx...
IXYS Introduces the IXRFD615 Ultrafast RF MOSFET Driver
Aug 15, 2017 12:30 pm UTC| Business
FORT COLLINS, Colo., Aug. 15, 2017 -- IXYS Corporation (NASDAQ:IXYS), a leader in power semiconductors, mixed-signal and digital ICs for power conversion and motion control applications, announced today the introduction...
VirTra Announces Details of Annual Shareholders Meeting
Aug 15, 2017 12:30 pm UTC| Business
TEMPE, Ariz., Aug. 15, 2017 -- VirTra, Inc. (OTCQX:VTSI), (the “Company”), a global provider of simulators for the law enforcement, military, educational and commercial markets, announced today that the Annual Meeting...
IGX Global Launches New Responsive Website
Aug 15, 2017 12:30 pm UTC| Business
HERNDON, Va., Aug. 15, 2017 -- ePlus inc. (NASDAQ:PLUS) today announced that its subsidiary located in London, IGX Global, has launched a new website at www.igxglobal.com. The responsive design helps users quickly...
Aug 15, 2017 12:29 pm UTC| Business
ATLANTA and AKRON, Ohio, Aug. 15, 2017 -- Vystar Corp. (OTC Market:VYST) Board of Directors Member and Research Development Director Ranjit K. Matthan, Ph.D., was a speaker at the International Latex Conference session...
As White Plains Continues to Grow, ENT and Allergy Associates Grows Right Along with It
Aug 15, 2017 12:28 pm UTC| Business
Tarrytown, NY, Aug. 15, 2017 -- Tarrytown, NY –August 15, 2017: ENT and Allergy Associates, LLP (ENTA), the foremost otolaryngology and allergy specialty and sub-specialty practice in the United States-with nearly 200...
Abeona Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
Aug 15, 2017 12:25 pm UTC| Business
NEW YORK and CLEVELAND, Aug. 15, 2017 -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases,...